US2074101013
US2074101013
CONMED Corporation
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.33B EUR | 986.6M EUR | 1.07B EUR | 1.26B EUR |
Enterprise Value | 2.15B EUR | 1.78B EUR | 1.89B EUR | 2.05B EUR |
Valuation Multiples | ||||
Trailing P/E | 24.01x | 17.46x | 19.43x | 30.65x |
Forward P/E | 9.29x | -- | -- | -- |
Price to Sales | 0.97x | 0.72x | 0.78x | 1.19x |
Price to Book | 1.28x | 0.95x | 1.05x | 1.22x |
EV/Revenue | 1.57x | 1.3x | 1.38x | 1.95x |
EV/EBITDA | 9.44x | 9.46x | 10.14x | 14.42x |
Price to FCF (P/FCF) | 10.13x | 7.34x | 8.62x | 11.12x |
EV/FCF | 16.35x | 13.26x | 15.29x | 18.13x |
FCF Yield | 9.87% | 13.63% | 11.61% | 9% |